Schor, Gary v. Abbott Laboratories

**Abbott Laboratories Antitrust Case** Gary Schor filed a lawsuit against Abbott Laboratories claiming the pharmaceutical company violated antitrust laws through its pricing practices. Schor argued that Abbott was using monopoly-like pricing strategies that illegally harmed competition in the market. The Court of Appeals ruled in favor of Abbott Laboratories and dismissed the case entirely. The court determined that Schor failed to present a valid legal claim. Specifically, the judges found that using pricing strategies alone—even if a company has significant market power—does not automatically violate federal antitrust laws under the Sherman Act. The court explained that "monopoly leveraging through pricing" by itself is not something that can be successfully challenged in court under antitrust rules. For workers, this ruling clarifies that companies with strong market positions have significant freedom to set their prices as they see fit. While this case focused on business competition rather than employment issues directly, it demonstrates how courts interpret antitrust laws. Workers should understand that pricing decisions by large employers or companies in their industry may not be legally challengeable, even when those companies have considerable market control. This affects the broader economic environment where people work.